20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T67767 | HIF-1 inhibitor-4 | HIF-1 inhibitor-4 | HIF |
HIF-1 inhibitor-4 (HIF-1 inhibitor-4) is a HIF-1 inhibitor with IC50 of 560 nM. HIF-1 inhibitor-4 reduces the HIF-1α protein level without affecting its mRNA level. | |||
T11561 | HIF-2α-IN-2 | HIF/HIF Prolyl-Hydroxylase , HIF | |
HIF-2α-IN-2 is a hypoxia-inducible factor (HIF-2α) inhibitor (IC50: 16 nM in scintillation proximity assay). | |||
T15482 | HIF-2α-IN-1 | HIF | |
HIF-2α-IN-1 is a potent HIF-2α inhibitor with IC50 values less than 500 nM. | |||
T50099 | HIF-2α-IN-4 | Others , HIF/HIF Prolyl-Hydroxylase | |
HIF-2a translation inhibitor is a compound used as a molecular building block. | |||
T67831 | HIF-2α agonist 2 | HIF/HIF Prolyl-Hydroxylase , HIF | |
HIF-2α agonist 2 is an HIF-2α agonist with an EC50 value of 1.68 μM for HIF-2α. HIF-2α agonist 2 can promote the stability of the ARNT A/B ring in the 3z structure of HIF-2a-ARNT complex without cytotoxicity to 786-o-Reh... | |||
T11562 | HIF-2α-IN-3 | HIF | |
HIF-2α-IN-3 is an allosteric inhibitor of HIF-2α (IC50: 0.4 μM; KD: 1.1 μM) with anticancer activity. | |||
T3180 | JNJ-42041935 | HIF-PHD Inhibitor II | HIF/HIF Prolyl-Hydroxylase |
JNJ-42041935 (HIF-PHD Inhibitor II) is a potent (pKi = 7.3-7.9), 2-oxoglutarate competitive, reversible, and selective inhibitor of PHD enzymes. | |||
T61349 | HIF-1α-IN-2 | HIF | |
HIF-1α-IN-2 is a novel and highly potent HIF-1α inhibitor with anticancer and antitumor activity that inhibits the expression of HIF-1α and VEGF in a dose-dependent manner and inhibits cell migration. | |||
T75098 | HIF-PHD-IN-3 | Reactive Oxygen Species | |
HIF-PHD-IN-3 is a potent hiPSC-CM cardioprotective scaffold with potential inhibitory effects on HIF-PHD, regulates heme oxygenase-1, and can be used to study anaemia. | |||
T25502 | HIF-IN-33 | HIF IN 33,HIF Pathway Inhibitor 33 | |
HIF-IN-33 is an inhibitor of HIF pathway. | |||
T3494 | LW6 | HIF-1α inhibitor,CAY10585,LW8 | Apoptosis , Dehydrogenase , HIF/HIF Prolyl-Hydroxylase , HIF |
LW6 (HIF-1α inhibitor) is a novel HIF-1 inhibitor. | |||
T36711 | FM19G11 | FM19G11,HIF-1alpha/2alpha Inhibitor | HIF |
FM19G11 is an inhibitor of hypoxia inducible factor (HIF) α-subunit (IC50 = 80 nM in hypoxia induced luciferase assay). | |||
TP1533 | HIF-1 alpha (556-574) | HIF-1 alpha 556-574 | |
HIF-1 alpha (556-574) is a hypoxia-inducible factor-1 19-mer fragment. HIF-1 functions as master regulator of response to oxygen homeostasis. Hypoxia-induced gene expression is initiated when HIF-1subunit is stabilized i... | |||
T39040 | HIF-PHD-IN-1 | ||
HIF-PHD-IN-1 is a pharmacological compound that acts as an orally active inhibitor of the hypoxia-inducible factor prolyl hydroxylase domain (HIF-PHD), displaying an IC50 of 54 nM for hHIF-PHD2. Its potential as a therap... | |||
T36290 | HIF-1 inhibitor-1 | ||
HIF-1 inhibitor-1 is an aryl carboxamide compound and a potent hypoxia-inducible factor 1 (HIF-1) inhibitor with an IC50 of 0.32 μM for the cancer metastasi[1]. [1]. Liu M, et al. Discovery of Novel Aryl Carboxamide Deri... | |||
TP1546 | HIF-1 alpha (556-574) TFA (1201633-99-9 free base) | HIF-1 alpha (556-574) TFA | |
This is a hypoxia-inducible factor-1 (HIF-1 a) 19-mer fragment. HIF-1 functions as master regulator of response to oxygen homeostasis. Hypoxia-induced gene expression is initiated when HIF-1 subunit is stabilized in resp... | |||
T60413 | HIF-IN-1 | HIF | |
HIF-IN-1 is a potent inhibitor of hypoxia-inducible factor (HIF-1), which is associated with tumor and cancer cell proliferation and inhibits HIF-1α protein aggregation. | |||
T61367 | HIF-2α-IN-6 | ||
HIF-2α-IN-6 (117) is a HIF-2α inhibitor [1]. | |||
T72997 | HIF-2α-IN-7 | ||
HIF-2α-IN-7 is a hypoxia inducible factor 2α (HIF-2α) inhibitor. HIF-2α-IN-7 can inhibit HIF-2α with an EC 50 value of 6 nM. HIF-2α-IN-7 can be used for the research of various types of diseases including cancer , liver ... | |||
T60524 | HIF-1α-IN-4 | ||
HIF-1α-IN-4 is an inhibitor of HIF-1α with IC50 of 24 nM in HEK293T cells which has potential antitumor effects. HIF-1α-IN-4 downregulates VEGF and PDK1 mRNA expressions under hypoxia [1]. |